Skip to content
PILLARS
HomeRecent BillsActionsMore
ExploreElectionsPresidential ActionsPoliticiansTrending Bills
WatchlistSettingsProfile
HomeRecent BillsActionsMore
PILLARS

The bills, politicians, and elections that shape your life, in plain English.

Get the App
Our Receipts
Sources & MethodologyApp DetailsSend Feedback
The Legal Stuff
Privacy PolicyTerms of ServiceContact Us
Find Us On
© 2026 Political Pillars Inc.Simplifying politics
Prescription Drug Cost Transparency Bill
Recent Bills/Prescription Drug Cost Transparency Bill

Prescription Drug Cost Transparency Bill

IntroducedFebruary 4, 2025
Introduced1 year ago
Intro
House
Senate
Pres
Introduced in House
Why This Matters

This bill establishes new reporting rules for pharmacy benefit managers to ensure transparency in prescription drug pricing under Medicare. It aims to help seniors understand their medication costs better.

If you are a senior on Medicare, this bill could help you see clearer information about your prescription drug costs.
Who this affects
Seniors · Medicare enrollees
What changes is this bill making?
  1. 1This bill requires pharmacy benefit managers to report on drug pricing and performance.
  2. 2It mandates clear definitions for drug types and pricing guarantees.
  3. 3Pharmacy benefit managers must submit annual reports detailing covered drugs and costs.
  4. 4The bill aims to improve transparency in prescription drug plans for Medicare recipients.
  5. 5It applies to plans starting January 1, 2028.
Read the detailed summary

Saving Seniors Money on Prescriptions Act This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs. Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e. g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations. In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

Bill Progress1 of 4
Bills must pass the House, Senate, and be signed by the President to become law.
Intro
House
Senate
Pres
IntroducedCurrentFeb 4, 2025

Introduced in House

Sponsors
See all 3 sponsors
House
Senate
President

The President

Donald Trump
President
Awaiting Vote
Similar Bills
House Bill · HR 6837
1 of 4 · Introduced
Pharmacy Benefit Manager Accountability Bill
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
·Healthcare
House Bill · HR 3789
1 of 4 · Introduced
Drug Price Transparency Bill
DTC Act of 2025
·Healthcare
House Bill · HR 6401
1 of 4 · Introduced
Monthly Cost Cap for Prescription Drugs
Increasing Medication Access for Seniors Act of 2025
·Healthcare